Renal transplantation for lupus nephritis: non-adherence and graft survival.

Abstract:

OBJECTIVES:Poor adherence to immunosuppressive treatment is common in patients with systemic lupus erythematosus and may identify those with lupus nephritis (LN) who have a poorer prognosis. Non-adherence has also been reported to be a potential adverse outcome predictor in renal transplantation (rTp). We investigated whether non-adherence is associated with increased rTp graft rejection and/or failure in patients with LN. METHODS:Patients with LN undergoing rTp in two major London hospitals were retrospectively included. Medical and electronic records were reviewed for documented concerns of non-adherence as well as laboratory biochemical drug levels. The role of non-adherence and other potential predictors of graft rejection/failure including demographics, comorbidities, age at systemic lupus erythematosus and LN diagnosis, type of LN, time on dialysis prior to rTp and medication use were investigated using logistic regression. RESULTS:Out of 361 patients with LN, 40 had rTp. During a median follow-up of 8.7 years, 17/40 (42.5%) of these patients had evidence of non-adherence. A total of 12 (30.0%) patients experienced graft rejection or failure or both. In the adherent group 2/23 (8.7%) had graft rejection, whilst in the non-adherent this rose to 5/17 (29.4%, p = 0.11). Graft failure was seen in 5/23 (21.7%) patients from the adherent group and 4/17 (23.5%) in the non-adherent group ( p = 0.89). Non-adherent patients had a trend towards increased graft rejection, hazard ratio 4.38, 95% confidence interval = 0.73-26.12, p = 0.11. Patients who spent more time on dialysis prior to rTp were more likely to be adherent to medication, p = 0.01. CONCLUSION:Poor adherence to immunosuppressive therapy is common and has been shown to associate with a trend towards increased graft failure in patients with LN requiring rTp. This is the first paper to report that shorter periods on dialysis prior to transplantation might lead to increased non-adherence in lupus patients.

journal_name

Lupus

journal_title

Lupus

authors

Ntatsaki E,Vassiliou VS,Velo-Garcia A,Salama AD,Isenberg DA

doi

10.1177/0961203319842641

subject

Has Abstract

pub_date

2019-04-01 00:00:00

pages

651-657

issue

5

eissn

0961-2033

issn

1477-0962

journal_volume

28

pub_type

杂志文章,多中心研究

相关文献

LUPUS文献大全
  • Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.

    abstract:INTRODUCTION:Complement activation is central to the pathogenesis of lupus nephritis (LN). Low serum complement C3 and C4, are traditionally used as markers of lupus disease activity in general and LN in particular. In this study we prospectively measured plasma and urine C3d and C4d, degradation products of C3 and C4 ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320950019

    authors: Ganguly S,Majumder S,Kumar S,Gupta R,Muhammed H,Shobha V,Aggarwal A,Misra R

    更新日期:2020-11-01 00:00:00

  • Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.

    abstract:OBJECTIVE:To investigate the predictive value of serum C3 and C4 complement component levels in relation to pregnancy outcome in patients with antiphospholipid syndrome (APS). MATERIALS AND METHODS:A prospective study of 47 pregnancies associated with APS was performed. Pregnancy outcome was analyzed in terms of: feta...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312444172

    authors: De Carolis S,Botta A,Santucci S,Salvi S,Moresi S,Di Pasquo E,Del Sordo G,Martino C

    更新日期:2012-06-01 00:00:00

  • Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.

    abstract::Proteinuria is a well-known risk factor for the progression of renal dysfunction in chronic kidney disease; however, its importance for estimating the prognosis of lupus nephritis requires verification. Korean adult patients with renal biopsy-diagnosed diffuse proliferative lupus nephritis who had undergone three or m...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315595130

    authors: Koo HS,Kim S,Chin HJ

    更新日期:2016-01-01 00:00:00

  • Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.

    abstract::Systemic lupus erythematosus (SLE) is characterized by multiple autoantibodies and complement activation. Recent studies have suggested that anti-nuclear antibody (ANA) positivity may disappear over time in some SLE patients. Anti-double-stranded DNA (dsDNA) antibody titers and complement levels may vary with time and...

    journal_title:Lupus

    pub_type: 历史文章,杂志文章

    doi:10.1177/0961203310385738

    authors: Ippolito A,Wallace DJ,Gladman D,Fortin PR,Urowitz M,Werth V,Costner M,Gordon C,Alarcón GS,Ramsey-Goldman R,Maddison P,Clarke A,Bernatsky S,Manzi S,Bae SC,Merrill JT,Ginzler E,Hanly JG,Nived O,Sturfelt G,Sanchez-Gu

    更新日期:2011-03-01 00:00:00

  • Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria.

    abstract::In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) group published a new set of classification criteria for systemic lupus erythematosus (SLE). Studies applying these criteria to real-life scenarios have found either equal or greater sensitivity and equal or lower specificity to the 1997 ACR class...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316657434

    authors: Ungprasert P,Sagar V,Crowson CS,Amin S,Makol A,Ernste FC,Osborn TG,Moder KG,Niewold TB,Maradit-Kremers H,Ramsey-Goldman R,Chowdhary VR

    更新日期:2017-03-01 00:00:00

  • Bone marrow analysis of immune cells and apoptosis in patients with systemic lupus erythematosus.

    abstract:OBJECTIVES:To examine the immune cell profile in the bone marrow of systemic lupus erythematosus (SLE) patients and to assess its clinical relevance. METHODS:Sixteen bone marrow samples from 14 SLE patients were compared with seven healthy control samples. The numbers of immune cells and apoptotic cells in the bone ma...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314531634

    authors: Park JW,Moon SY,Lee JH,Park JK,Lee DS,Jung KC,Song YW,Lee EB

    更新日期:2014-09-01 00:00:00

  • Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.

    abstract::Mesenchymal stem cells have been applied to treat graft versus host disease as they have immunosuppressive ability and can overcome the major histocompatibility complex-histocompatibility barrier. The potential of allogeneic mesenchymal stem cells in treating systemic lupus erythematosus (SLE) was investigated in this...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320928419

    authors: Liu F,Chen H,Chen T,Lau CS,Yu FX,Chen K,Chen HP,Pan RS,Chan GC,Zhang XY,Nie YJ

    更新日期:2020-07-01 00:00:00

  • Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

    abstract:OBJECTIVE:The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from neuropsychiatric systemic lupus erythematosus (NPSLE) patients in comparison to controls and to investigate if different types of immunosuppressive treatments were co...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312470977

    authors: Iacobaeus E,Hopia L,Khademi M,Lundén M,Hammarin AL,Svenungsson E,Andersson M

    更新日期:2013-03-01 00:00:00

  • Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults.

    abstract::Data on the clinical and laboratory profiles of 83 children with SLE have been analysed and compared with data on 187 adults with the disease. The clinical features of childhood SLE are similar to those seen in adults, although clinical and laboratory parameters reflect propensity to a more severe form of the disease ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200204

    authors: Pande I,Sekharan NG,Kailash S,Uppal SS,Singh RR,Kumar A,Malaviya AN

    更新日期:1993-04-01 00:00:00

  • Sinus node disfunction in an adolescent with systemic lupus erythematosus.

    abstract::Cardiac involvement in systemic lupus erythematosus (SLE) is well documented. The pericardium, myocardium and endocardium, as well as the coronary arteries, the valves and the conduction system can all be affected. While pericarditis is common, arrythmias are less frequently described.We present a 13-year-old male, wh...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320974091

    authors: Fogaça da Mata M,Rebelo M,Sousa HS,Rocha A,Miguel P,Oliveira Ramos F,Costa-Reis P

    更新日期:2020-11-20 00:00:00

  • Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.

    abstract::Numerous drugs have been linked to the induction or exacerbation of systemic cutaneous lupus erythematosus (SCLE). This report presents the third case of the biologic abatacept as an exacerbating medication for SCLE. A 73-year old woman with a remote history of subacute cutaneous lupus and rheumatoid arthritis, well c...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320981146

    authors: Figueredo Zamora E,Callen JP,Schadt CR

    更新日期:2020-12-22 00:00:00

  • Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in Poland.

    abstract::The contribution of the p53 Arg72Pro polymorphism in the development of systemic lupus erythematosus (SLE) remains controversial. We investigated the frequency of the p53 Arg72Pro genotype in patients with SLE (n = 155) and in controls (n = 150) in Poland. We found a weak contribution of the Arg/Arg genotype to the mo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307084722

    authors: Piotrowski P,Lianeri M,Mostowska M,Wudarski M,Chwalinska-Sadowska H,Jagodzinski PP

    更新日期:2008-02-01 00:00:00

  • Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial.

    abstract:OBJECTIVE:Studies have been conducted to determine the causal factors and clinical consequences of non-adherence to treatment in systemic lupus erythematosus (SLE). However, no interventions have been performed to increase drug adherence. Our objective was to assess the effectiveness of pharmaceutical care (PC) for dru...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203319877237

    authors: Oliveira-Santos M,Verani JFS,Camacho LAB,de Andrade CAF,Klumb EM

    更新日期:2019-10-01 00:00:00

  • Infant perinatal thrombosis and antiphospholipid antibodies: a review.

    abstract::Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops feta...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203307079039

    authors: Boffa MC,Lachassinne E

    更新日期:2007-01-01 00:00:00

  • Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study.

    abstract::Gamma-aminobutyric acid-A (GABA-A) receptors play a crucial role in regulating neuronal excitability and cognitive functions. Single-photon emission computerized tomography (SPECT) analysis of GABA-A receptors binding by (123)I-labelled Iomazenil ((123)I-IMZ) has been applied in some neuropsychiatric disorders to inve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203310364398

    authors: Mathieu A,Vacca A,Serra A,Cauli A,Piga M,Porru G,Marrosu F,Sanna G,Piga M

    更新日期:2010-07-01 00:00:00

  • Interstitial inflammation and long-term renal outcomes in lupus nephritis.

    abstract:INTRODUCTION:The International Society of Nephrology/Renal Pathology Society (ISN/RPS) pathological classification criteria of lupus nephritis are limited to glomerular injury. Although the tubulointerstitium is commonly involved, the importance of such involvement is not well defined. The major objective of this study...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313507986

    authors: Alsuwaida AO

    更新日期:2013-12-01 00:00:00

  • Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.

    abstract::We investigated the clinical significance of IgG phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera were examined for IgG phospholipid-dependent anti-beta 2-GPI antibodies by ELISA. IgG phospholipid-dependent ant...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400609

    authors: Kaburaki J,Kuwana M,Yamamoto M,Kawai S,Matsuura E,Ikeda Y

    更新日期:1995-12-01 00:00:00

  • Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.

    abstract::We retrospectively analysed the prevalence and clinical features associated to anti-Ku antibodies in patients affected by different autoimmune diseases. Anti-Ku antibodies are detected in 147 sera out of 7239 anti-ENA positive sera (2%). They are found in 2% of patients with systemic sclerosis (SSc) (8 out of 379), 1....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089442

    authors: Cavazzana I,Ceribelli A,Quinzanini M,Scarsi M,Airò P,Cattaneo R,Franceschini F

    更新日期:2008-08-01 00:00:00

  • HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.

    abstract::The objective of this study was to determine the HLA class II associations of the anticardiolipin (aCL) and anti-beta2GPI (abeta2GPI) antibodies in a large series of European patients with systemic lupus erythematosus (SLE). A cohort of 577 European SLE patients was enrolled. aCL and abeta2GPI were measured by ELISA m...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1177/096120330000900109

    authors: Galeazzi M,Sebastiani GD,Tincani A,Piette JC,Allegri F,Morozzi G,Bellisai F,Scorza R,Ferrara GB,Carcassi C,Font J,Passiu G,Smolen J,Papasteriades C,Houssiau F,Nebro AF,Ramon Garrido ED,Jedryka-Goral A,Marcolongo R

    更新日期:2000-01-01 00:00:00

  • Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.

    abstract::The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600413

    authors: Muñoz-Rodríguez FJ,Font J,Badia JR,Miret C,Barberà JA,Cervera R,Ingelmo M

    更新日期:1997-01-01 00:00:00

  • 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.

    abstract::Obstetric antiphospholipid syndrome (APS) remains a clinical challenge for practitioners, with several controversial points that have not been answered so far. This Obstetric APS Task Force met on the 16th International Congress on Antiphospholipid Antibodies in Manchester, England, to discuss about treatment, diagnos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320954520

    authors: de Jesús GR,Benson AE,Chighizola CB,Sciascia S,Branch DW

    更新日期:2020-10-01 00:00:00

  • Identification and characterization of a new human DNA reactive monoclonal antibody and a common idiotype, WRI 176 Id beta.

    abstract::We describe a human monoclonal antibody designated WRI 176 beta and a common idiotype that it carries. This antibody was derived from the spleen of a patient with SLE. WRI 176 is an IgM kappa monoclonal reacting with ssDNA, dsDNA, poly(dT) and it is likely that mAb WRI 176 beta is a representative of the so-called nat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300105

    authors: Blanco F,Longhurst C,Watts R,Kalsi J,Wiloch HW,Youinou P,Latchman DS,Isenberg DA

    更新日期:1994-02-01 00:00:00

  • Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

    abstract::The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its association with the main clinical, hematological and immunological fea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1080oa

    authors: Ramos-Casals M,Campoamor MT,Chamorro A,Salvador G,Segura S,Botero JC,Yagüe J,Cervera R,Ingelmo M,Font J

    更新日期:2004-01-01 00:00:00

  • Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study.

    abstract:BACKGROUND:Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and life-threatening condition with poor prognosis in patients with antiphospholipid syndrome (APS). Pulmonary thromboendarterectomy (PTE) is the optimal surgical option for CTEPH. OBJECTIVES:This retrospective cohort study aimed to evaluate th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318810427

    authors: Li C,Zhao J,Liu S,Song W,Zhu J,Hua L,Wang Q,Li M,Zeng X,Zhao Y

    更新日期:2018-12-01 00:00:00

  • Acute sideroblastic anemia in active systemic lupus erythematosus.

    abstract::This work describes the development of sideroblastic anemia (SA) during the clinical activity of systemic lupus erythematosus (SLE) in two patients. The cases refer to two women with SLE who developed SA during a relapse of the illness. Both patients fulfilled at least four criteria of the American Association of Rheu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300305

    authors: Jiménez-Balderas FJ,Morales-Polanco MR,Gutierrez L

    更新日期:1994-06-01 00:00:00

  • Mycophenolate mofetil in nonlupus glomerulonephropathy.

    abstract::Mycophenolate mofetil (MMF) initially found widespread use in the immunoprophylaxis of rejection in organ transplantation. It has subsequently been used in lupus glomerulonephritis, where early studies have shown it to be effective in induction and maintenance therapy. The randomized studies have mostly studied small ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2116oa

    authors: Karim MY,Abbs IC

    更新日期:2005-01-01 00:00:00

  • Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.

    abstract:OBJECTIVES:To estimate the prevalence of pulmonary arterial hypertension (PAH) and risk factors for PAH in patients registered in the Chinese SLE Treatment and Research group (CSTAR) database, the first online registry of Chinese patients with systemic lupus erythematosus (SLE). METHODS:A prospective cross-sectional s...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314527366

    authors: Li M,Wang Q,Zhao J,Li Z,Ye Z,Li C,Li X,Zhu P,Wang Z,Zheng Y,Li X,Zhang M,Tian Z,Liu Y,He J,Zhang F,Zhao Y,Zeng X,CSTAR co-authors.

    更新日期:2014-09-01 00:00:00

  • Antiphospholipid syndrome: clinical and therapeutic aspects.

    abstract::The purpose of the present study was to evaluate patients with the antiphospholipid syndrome with particular attention to their initial clinical features, final diagnoses and the course of thrombotic events in association with therapy. The methodology applied was the following: retrospective analysis of 30 patient fil...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300206

    authors: Vlachoyiannopoulos PG,Tsiakou E,Chalevelakis G,Raptis SA,Moutsopoulos HM

    更新日期:1994-04-01 00:00:00

  • C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.

    abstract:BACKGROUND:Complement activation plays a role in pathogenesis of the antiphospholipid syndrome (APS), but the involvement of the C5b-9 membrane attack complex (MAC) is unknown. Here we studied the effects of human polyclonal antiphospholipid (aPL) antibodies on thrombosis and tissue factor (TF) up-regulation in C6 defi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312458839

    authors: Carrera-Marín A,Romay-Penabad Z,Papalardo E,Reyes-Maldonado E,García-Latorre E,Vargas G,Shilagard T,Pierangeli S

    更新日期:2012-12-01 00:00:00

  • Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies.

    abstract::The presence of antibodies against the complex of prothrombin and phosphatidylserine (aPS/PT) more significantly correlates with manifestations of antiphospholipid syndrome (APS) and with the presence of lupus anticoagulants (LA) than antibodies against prothrombin bound to oxygenated polystyrene (aPT-A). To investiga...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307078680

    authors: Horita T,Ichikawa K,Kataoka H,Yasuda S,Atsumi T,Koike T

    更新日期:2007-01-01 00:00:00